PA Kaufman

Abstract PD6-13: Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer

SM Tolaney, Kevin Kalinsky, Virginia Kaklamani et al. · Cancer Research · 2018 · 71 citations

Medicine, Oncology, Pharmacology +17

Abstract S6-6: A Phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes

PA Kaufman, Ahmad Awada, Chris Twelves et al. · Cancer Research · 2012 · 48 citations

Medicine, Oncology, Pharmacology +16

Abstract S1-4: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of AMG 479 With Exemestane (E) or Fulvestrant (F) in Postmenopausal Women With Hormone-Receptor Positive (HR+) Metastatic (M) or Locally Advanced (LA) Breast Cancer (BC)

PA Kaufman, J-M Ferrero, Hugues Bourgeois et al. · Cancer Research · 2010 · 45 citations

Medicine, Endocrinology, Oncology +16

Paclitaxel and anthracycline combination chemotherapy for metastatic breast cancer.

PA Kaufman · PubMed · 1999 · 40 citations

Medicine, Oncology, Pharmacology +13

Phase II, 3-arm study of CCI-779 in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer: preliminary results

José Baselga, P. Fumoleau, M. Gil et al. · Journal of Clinical Oncology · 2004 · 35 citations

Medicine, Oncology, Pharmacology +17